Enveric Biosciences (ENVB) Change in Account Payables (2010 - 2026)
Enveric Biosciences (ENVB) posted Change in Account Payables of -$99875.0 for Q1 2026, down 200.0% sequentially from $99875.0 in Q4 2025, and up 24.06% YoY from -$80506.3 in Q1 2025.
Enveric Biosciences (ENVB) Change in Account Payables (2010 - 2026) Analysis & Trends
Enveric Biosciences has reported Change in Account Payables for 4 years, with the latest figure at -$99875.0 in Q1 2026.
- Quarterly Change in Account Payables rose 24.06% year-over-year to -$99875.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$101375.0 (changed N/A YoY) and the FY2025 annual result came in at -$133016.0, down 157.12% from the prior year.
- Change in Account Payables fell to -$99875.0 in Q1 2026 per ENVB's latest filing, from $99875.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $99875.0 in Q4 2025 and troughed at -$131516.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Enveric Biosciences | 5.66 Mn | -2.64 Mn | - | 26,750.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -99,875.00 |
| Mar 31, 2026 | -99,875.00 |
| Dec 31, 2025 | 99,875.00 |
| Dec 31, 2025 | 99,875.00 |
| Sep 30, 2025 | -99,875.00 |
| Sep 30, 2025 | -99,875.00 |
| Jun 30, 2025 | -1,500.00 |
| Jun 30, 2025 | -1,500.00 |
| Mar 31, 2025 | -131,516.00 |
| Mar 31, 2025 | -131,516.00 |
| Sep 30, 2011 | -1.00 |
| Sep 30, 2011 | -1.00 |
| Sep 30, 2010 | -788.00 |
| Sep 30, 2010 | -788.00 |